Scientific illustration of a lab mouse with regenerating small intestine linked to cysteine-rich diet for MIT study news.
Scientific illustration of a lab mouse with regenerating small intestine linked to cysteine-rich diet for MIT study news.
በ AI የተሰራ ምስል

MIT study links dietary cysteine to faster small-intestine repair in mice

በ AI የተሰራ ምስል
እውነት ተፈትሸ

MIT researchers report that the amino acid cysteine, found in many protein-rich foods, can enhance the small intestine’s ability to regenerate after injury in mice by triggering an immune-to-stem-cell signaling cascade. The work, published in Nature, raises the possibility—still untested in people—that diet or supplementation could someday help ease some treatment-related intestinal damage during radiation or chemotherapy.

MIT scientists say they have identified cysteine as a dietary nutrient that can amplify tissue repair in the small intestine after injury.

In mouse experiments, a cysteine-enriched diet expanded and activated CD8 T cells in the intestinal lining. Those immune cells produced the cytokine IL-22, which the researchers said helps stimulate intestinal stem cells to rebuild damaged tissue.

Mice fed a cysteine-rich diet recovered better after radiation exposure, the researchers reported. The team also said it saw similar regenerative effects in unpublished experiments using the chemotherapy drug 5-fluorouracil.

Cysteine occurs naturally in many high-protein foods, including meat, dairy products, legumes such as beans, and nuts, according to the MIT summary of the work.

ሰዎች ምን እያሉ ነው

Initial reactions on X focus on the MIT study's finding that dietary cysteine enhances intestinal stem cell repair in mice via immune signaling, with users noting potential applications for cancer patients recovering from radiation or chemotherapy damage. Posts emphasize the mechanistic details from rodent models, express cautious optimism about human translation, and highlight cysteine-rich foods like meat, dairy, and nuts as possible dietary aids, while stressing that further research is needed.

ተያያዥ ጽሁፎች

Medical illustration depicting the tripeptide DT-109 improving fatty liver disease by strengthening the gut barrier in animal models.
በ AI የተሰራ ምስል

Experimental tripeptide DT-109 improved severe fatty liver disease in animal studies by strengthening the gut barrier

በAI የተዘገበ በ AI የተሰራ ምስል እውነት ተፈትሸ

A glycine-based experimental tripeptide developed at Michigan Medicine improved metabolic dysfunction–associated steatohepatitis (MASH) in mice and nonhuman primates, with researchers linking the benefit to reduced gut-derived ammonia and a stronger intestinal barrier, according to a study in The Journal of Clinical Investigation.

Researchers reported at Digestive Disease Week (DDW) 2026 that older mice given fecal microbiota transplants made from their own preserved, younger-age stool samples showed less liver inflammation and injury—and none developed liver cancer in the experiment.

በAI የተዘገበ

A modified Mediterranean-style diet low in protein but supplemented with methionine helped older mice stay healthier while eating more food. Researchers at the University of Southern California led the study, which also drew on human data linking lower animal protein intake to reduced obesity and diabetes rates. The findings were published in Cell Metabolism.

A study in mice has found that transplanting gut microbes from young animals into older ones can restore youthful levels of brain plasticity. The research points to potential new ways of treating conditions that are normally only reversible in childhood.

በAI የተዘገበ

Researchers in Sweden have created insulin-producing cells from human stem cells that reversed diabetes symptoms when transplanted into mice. The cells matured after placement in the eye and maintained glucose regulation for months. The work was published in Stem Cell Reports.

ይህ ድረ-ገጽ ኩኪዎችን ይጠቀማል

የእኛን ጣቢያ ለማሻሻል ለትንታኔ ኩኪዎችን እንጠቀማለን። የእኛን የሚስጥር ፖሊሲ አንብቡ የሚስጥር ፖሊሲ ለተጨማሪ መረጃ።
ውድቅ አድርግ